Summary
For a compound to inhibit potently the transformation of amorphous calcium phosphate into hydroxyapatite, it is suggested that the minimum structural requirement is a phosphate group and, at some other position, either another phosphate group preferably or a carboxylic moiety. Primary amino groups abolish inhibitor potential. Inhibitor potency is modified by various secondary factors, including the number and proximity of active groups, their stereochemistry, steric factors, the lability of the molecule, and in special instances its lipophilicity. Parameters used to monitor the transformation indicate that inhibitors can be grouped into two classes, and it is suggested that this is because one class acts as a hydroxyapatite crystal growth inhibitor. The close proximity of two phosphate groups or of a phosphate and multiple carboxylic groups is proposed to determine in part whether or not a compound acts as a crystal growth inhibitor. Further, bulky side groups render a molecule inactive as a crystal growth poison, although it will still inhibit by other mechanisms.
Similar content being viewed by others
References
Termine, J. D., Conn, K. M.: Inhibition of apatite formation by phosphorylated metabolites and macromolecules, Calcif. Tissue Res.22:149–157, 1976
Termine, J. D., Peckauskas, R. A., Posner, A. S.: Calcium phosphate formationin vitro II. Effects of environment on amorphous-crystalline transformation, Arch. Biochem. Biophys.140:318–325, 1970
Fleisch, H., Bisaz, S.: Isolation from urine of pyrophosphate, a calcification inhibitor, Am. J. Physiol.203:671–675, 1962
Van Den Berg, C. J., Hill, L. F., Stanbury, S. W.: Inositol phosphates and phytic acid as inhibitors of biological calcification in the rat, Clin. Sci.43:377–383, 1972
Williams, G., Sallis, J. D.: Structure-activity relationship of inhibitors of hydroxyapatite formation, Biochem. J.184:181–184, 1979
Williams, G., Holdsworth, E. S., Sallis, J. D.: Phosphocitrate, a new compound for consideration in the control of biological calcification, Clin. Exp. Pharm. Physiol.7:42–43, 1980
Meyer, J. L., Nancollas, G. H.: The influence of multidentate organic phosphates on the crystal growth of hydroxyapatite, Calcif. Tissue Res.13:295–303, 1973
Hay, D. I., Moreno, E. C., Schlesinger, D. H.: Phosphoprotein-inhibitors of calcium phosphate precipitation from salivary secretions, Inorgan. Perspect. Biol. Med.2:271–285, 1979
Robertson, W. G., Fleisch, H.: The effect of imidodiphosphate (P-N-P) on the precipitation and dissolution of calcium phosphatein vitro, Biochem. Biophys. Acta222:677–680, 1970
Yount, R. G.: Adenylylimidodiphosphate and guanylylimidodiphosphate, Methods Enzymol.138C:420–427, 1974
Williams, G., Sallis, J. D.: The synthesis of unlabelled and32P-labelled phosphocitrate and analytical systems for its identification, Anal. Biochem.102:365–373, 1980
Meyer, J. L., Eanes, E. D.: A thermodynamic analysis of the amorphous to crystalline calcium phosphate transformation, Calcif. Tissue Res.25:59–68, 1978
Termine, J. D., Eanes, E. D.: Comparative chemistry of amorphous and apatitic calcium phosphate preparations, Calcif. Tissue Res.10:171–197, 1972
Eanes, E. D., Termine, J. D., Nylen, M. U.: An electron microscope study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite, Calcif. Tissue Res.12:143–160, 1976
Francis, M. D.: The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates, Calcif. Tissue Res.3:151–162, 1969
Boskey, A. L., Posner, A. S.: Conversion of amorphous calcium phosphate to microcrystalline hydroxyapatite. A pH dependent solution-mediated, solid-solid conversion, J. Phys. Chem.77:2312–2314, 1973
Despotavic, R., Filipovic-Vincekovic, N., Füredi-Milhofer, H.: Precipitation of calcium phosphates from electrolyte solutions. III. Radiometric studies of the kinetics of precipitation and aging of calcium phosphates, Calcif. Tissue Res.18:13–26, 1975
Nancollas, G. H., Mohan, M. S.: The growth of hydroxyapatite crystals, Arch. Oral Biol.15:731–745, 1970
Williams, G., Sallis, J. D.: The sources of phosphocitrate and its influential role in inhibiting calcium phosphate and calcium oxalate crystallization, Proc. Fourth Int. Symp. Urolith. Res. 1980, in press
Tew, W. P., Mahle, C., Benavides, J., Howard, J. E., Lehninger, A. L.: Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxyapatite crystal growth, Biochemistry19:1983–1988, 1980
Wuthier, R. E., Eanes, E. D.: Effect of phospholipids on the transformation of amorphous calcium phosphate to hydroxyapatitein vitro, Calcif. Tissue Res.19:197–210, 1975
Krane, S. M., Glimcher, M. J.: Transphosphorylation from nucleoside di- and triphosphates by apatite crystals, J. Biol. Chem.237:2991–2998, 1962
Fleisch, H., Russell, R. G. G., Bisaz, S., Termine, J. D., Posner, A. S.: Influence of pyrophosphate on the transformation of amorphous to crystalline calcium phosphate, Calcif. Tissue Res.2:49–59, 1968
Blumenthal, N. C., Betts, F., Posner, A. S.: Stabilization of amorphous calcium phosphate by Mg and ATP, Calcif. Tissue Res.23:245–250, 1977
Fleisch, H.: Inhibitors and promoters of stone formation, Kidney Int.13:361–371, 1978
Posner, A. S., Betts, F.: Synthetic amorphous calcium phosphate and its relation to bone mineral structure, Acc. Chem. Res.8:273–280, 1975
Posner, A. S., Betts, F., Blumenthal, N. C.: Properties of nucleating systems, Metab. Bone Dis.1:179–184, 1978
Kawasaki, T.: Theory of chromatography of rigid molecules on hydroxyapatite columns with small loads. IV. Estimation of the adsorption energy of nucleoside polyphosphates, J. Chromatogr.151:95–112, 1978
Jung, A., Bisaz, S., Fleisch, H.: The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals, Calcif. Tissue Res.11:269–280, 1973
Taves, D. R., Reedy, R. C.: A structural basis for the transphosphorylation of nucleotides with hydroxyapatite, Calcif. Tissue Res.3:284–292, 1969
Blumenthal, N. C., Betts, F., Posner, A. S.: Nucleotide stabilization of amorphous calcium phosphate, Mater. Res. Bull.10:1055–1060, 1975
Boskey, A. L., Posner, A. S.: Magnesium stabilization of amorphous calcium phosphate: a kinetic study, Mater. Res. Bull.9:907–916, 1974
Blumenthal, N. C., Posner, A. S., Silverman, L. D., Rosenberg, L. C.: Effect of proteoglycans onin vitro hydroxyapatite formation, Calcif. Tissue Int.27:75–82, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, G., Sallis, J.D. Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calcif Tissue Int 34, 169–177 (1982). https://doi.org/10.1007/BF02411229
Issue Date:
DOI: https://doi.org/10.1007/BF02411229